A practical overview of pediatric atopic dermatitis, Part 3: Differential diagnosis, comorbidities, and measurement of disease burden

Cutis

Volumn 97, Issue 6, 2016, Pages 408-412

  Silverberg, Nanette B ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ANXIETY; CHILD; COMORBIDITY; COST OF ILLNESS; DEPRESSION; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; DIFFERENTIAL DIAGNOSIS; ECONOMICS; FAMILY; HUMAN; LYMPHOMA; MENTAL DISORDERS; MENTAL STRESS; OBESITY; PHOBIA; PSYCHOLOGY; SKIN DISEASES, INFECTIOUS; SUICIDAL IDEATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANXIETY; CHILD; COMORBIDITY; COST OF ILLNESS; DEPRESSION; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; FAMILY; HUMANS; LYMPHOMA; MENTAL DISORDERS; OBESITY; PHOBIC DISORDERS; SKIN DISEASES, INFECTIOUS; STRESS, PSYCHOLOGICAL; SUICIDAL IDEATION;

EID: 85013335810     PISSN: 00114162     EISSN: 23266929     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Silverberg NB. A practical overview of pediatric atopic dermatitis, part 1: Epidemiology and pathogenesis. Cutis. 2016;97:267-271.
2. Silverberg NB. A practical overview of pediatric atopic dermatitis, part 2: Triggers and grading. Cutis. 2016; 97:326-329.
3. Siegfried EC, Hebert AA. Diagnosis of atopic dermatitis: mimics, overlaps, and complications. J Clin Med. 2015;4:884-917.
4. Allen A, Siegfried E, Silverman R, et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol. 2001;137:747-750.
5. Carr WW. Topical calcineurin inhibitors for atopic dermatitis: Review and treatment recommendations. Paediatr Drugs. 2013;15:303-310.
6. Chamlin SL, Lai JS, Cella D, et al. Childhood Atopic Dermatitis Impact Scale: Reliability, discriminative and concurrent validity, and responsiveness. Arch Dermatol. 2007;143:768-772.
7. Tollefson MM, Bruckner AL. Atopic dermatitis: skin-directed management. Pediatrics. 2014;134:E1735-E1744.
8. Chamlin SL, Cella D, Frieden IJ, et al. Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol. 2005;125:1106-1111.
9. Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol. 2002;41:151-158.
10. Halvorsen JA, Lien L, Dalgard F, et al. Suicidal ideation, mental health problems, and social function in adolescents with eczema: A population-based study. J Invest Dermatol. 2014;134:1847-1854.
11. Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: A cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135:984-991.
12. Legendre L, Barnetche T, Mazereeuw-Hautier J, et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-Analysis. J Am Acad Dermatol. 2015;72:992-1002.
13. Koutroulis I, Magnelli L, Gaughan J, et al. Atopic dermatitis is more severe in children over the age of two who have an increased body mass index. Acta Paediatr. 2015;104:713-717.
14. Silverberg JI, Becker L, Kwasny M, et al. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol. 2015;151:144-152.
15. De D, Kanwar AJ, Handa S. Comparative efficacy of Hanifin and Rajka's criteria and the UK working party's diagnostic criteria in diagnosis of atopic dermatitis in a hospital setting in North India. J Eur Acad Dermatol Venereol. 2006;20:853-859.
16. Silverberg JI, Silverberg NB. Childhood atopic dermatitis and warts are associated with increased risk of infection: A US population-based study [published online October 4, 2013]. J Allergy Clin Immunol. 2014;133:1041-1047.
17. Silverberg J, Garg N, Silverberg NB. New developments in comorbidities of atopic dermatitis. Cutis. 2014;93:222-224.
18. Kiken DA, Silverberg NB. Atopic dermatitis in children, part 1: Epidemiology, clinical features, and complications. Cutis. 2006;78:241-247.
19. Mathes EF, Oza V, Frieden IJ, et al. "Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics. 2013;132:E149-E157.
20. Vora RV, Pilani AP, Jivani NB, et al. Kaposi varicelliform eruption. Indian Dermatol Online J. 2015;6:364-366.
21. Hata TR, Kotol P, Boguniewicz M, et al. History of eczema herpeticum is associated with the inability to induce human β-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis. Br J Dermatol. 2010;163:659-661.
22. Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol. 1998;139:13-16.
23. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90:525-530.
24. Lipnharski C, d'Azevedo PA, Quinto VP, et al. Colonization by S. aureus increases the EASI and the number of appointments by patients with atopic dermatitis: cohort with 93 patients. An Bras Dermatol. 2013;88:518-521.
25. Paller AS. Latest approaches to treating atopic dermatitis. Chem Immunol Allergy. 2012;96:132-140.
26. Groner A, Laing-Grayman D, Silverberg NB. Outpatient pediatric community-Acquired methicillin-resistant Staphylococcus aureus: A polymorphous clinical disease. Cutis. 2008;81:115-122.
27. Sugarman JL, Hersh AL, Okamura T, et al. A retrospective review of streptococcal infections in pediatric atopic dermatitis. Pediatr Dermatol. 2011;28:230-234.
28. Heath C, Desai N, Silverberg NB. Recent microbiological shifts in perianal bacterial dermatitis: Staphylococcus aureus predominance. Pediatr Dermatol. 2009;26:696-700.
29. Garg N, Silverberg JI. Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. Ann Allergy Asthma Immunol. 2014;112:525-532.
30. Lavery MJ, Stull C, Kinney MO, et al. Nocturnal pruritus: The battle for a peaceful night's sleep. Int J Mol Sci. 2016;17:E425.
31. Silverberg NB, Licht J, Friedler S, et al. Nickel contact hypersensitivity in children. Pediatr Dermatol. 2002;19:110-113.
32. Aubert-Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: A study of its nature, origins and frequency. Br J Dermatol. 2011;165:808-814.
33. Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30:29-35.
34. Silverberg JI. Health care utilization, patient costs, and access to care in US adults with eczema: A population-based study. JAMA Dermatol. 2015;151:743-752.
35. Weinmann S, Kamtsiuris P, Henke KD, et al. The costs of atopy and asthma in children: Assessment of direct costs and their determinants in a birth cohort. Pediatr Allergy Immunol. 2003;14:18-26.
36. Fivenson D, Arnold RJ, Kaniecki DJ, et al. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm. 2002;8:333-342.
37. Verboom P, Hakkaart-Van L, Sturkenboom M, et al. The cost of atopic dermatitis in the Netherlands: An international comparison. Br J Dermatol. 2002; 147:716-724.
38. Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: Who cares? who pays? J Am Acad Dermatol. 1993;28:699-703.
39. Carroll CL, Balkrishnan R, Feldman SR, et al. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22:192-199.
40. Ellis CN, Drake LA, Prendergast MM, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol. 2002;46:361-370.
41. Ellis CN, Prendergast MM, Tokar M, et al. Quantifying costs associated with atopic dermatitis. J Manag Care Pharm. 2003;9:278.
42. Lee SW, Cheong SH, Byun JY, et al. Occupational hand eczema among nursing staffs in Korea: self-reported hand eczema and contact sensitization of hospital nursing staffs. J Dermatol. 2013;40:182-187.
43. Kemp AS. Cost of illness of atopic dermatitis in children: A societal perspective. Pharmacoeconomics. 2003; 21:105-113.
44. Munro DD. Topical corticosteroid therapy and its effect on the hypothalamic-pituitary-Adrenal axis. Dermatologica. 1976;152:173-180.
45. Silverberg JI, Garg NK, Paller AS, et al. Sleep disturbances in adults with eczema are associated with impaired overall health: A US population-based study. J Invest Dermatol. 2015;135:56-66.
46. Eichenfield LF. Improving outcomes in atopic dermatitis. for advances in dermatology. Dermatology Focus. 2015;34:1-6.
47. Fleischer AB Jr. Black box warning for topical calcineurin inhibitors and the death of common sense. Dermatol Online J. 2006;12:2.